Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alisa Coker

Surgery Baltimore, MD Medical Doctor

NPI 1477888212 CMS profile 1003514

600 N Wolfe St, Blalock 618, Baltimore, MD 21287

Open in the dashboard

General payments

$701,843

876 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alisa Coker of Baltimore, MD is reported in the CMS Open Payments database as having received $701,843 across 876 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $105,721 155
2024 General $108,745 160
2023 General $125,576 167
2022 General $143,098 164
2021 General $89,407 81
2020 General $84,148 55
2019 General $45,149 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alisa Coker
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Alisa Coker were reported at $105,721. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Alisa Coker Surgery median Middle half National median
2019 $45,149 $253 $82–$1,521 $163
2020 $84,148 $131 $40–$706 $114
2021 $89,407 $168 $50–$904 $132
2022 $143,098 $224 $76–$1,218 $149
2023 $125,576 $253 $82–$1,255 $160
2024 $108,745 $279 $90–$1,381 $164
2025 $105,721 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $679,459 797 payments
  2. Davol Inc. $14,058 39 payments
  3. Allergan Inc. $5,577 12 payments
  4. W. L. Gore & Associates, Inc. $2,019 22 payments
  5. Covidien LP $300 1 payment
  6. TELA Bio, Inc. $173 1 payment
  7. AbbVie, Inc. $84 1 payment
  8. CONMED Corporation $77 1 payment
  9. Endolumik, Inc. $75 1 payment
  10. Ethicon US, LLC $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $385,829 153 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $202,980 69 payments
  3. Travel and Lodging $79,028 419 payments
  4. Food and Beverage $18,703 218 payments
  5. Honoraria $9,750 1 payment
  6. Consulting Fee $5,436 11 payments
  7. Gift $116 5 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $621,159 773 payments
  2. DA VINCI SP $58,300 24 payments
  3. STRATTICE RECONSTRUCTIVE TISSUE MATRIX BPS $3,120 6 payments
  4. STRATTICE $2,541 7 payments
  5. Phasix Mesh Surgery $2,520 22 payments
  6. SEAMGUARD Bioabsorbable Staple Line Reinforcement $1,117 9 payments
  7. SYNECOR Biomaterial $804 10 payments
  8. ProGrip $300 1 payment
  9. Phasix Mesh BD Interventional Surgery $192 2 payments
  10. OviTex 2S $173 1 payment
  11. Other $291 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 26 billing codes

Paid by Medicare

$43,544

Medicare's payments for the services billed

Medicare patients

95

Average age 70

Services billed

144

52 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Diabetes 31%
Ischemic heart disease 28%
Depression 26%
Chronic kidney disease 25%
Cancer 25%
Heart failure 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

876 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record